Also, some confounding factors, such as patient comorbidities (in our study most common comorbidities were included in statistical analysis such as HTA and diabetes mellitus) and relevant molecular markers (e.g., BRAF, RAS, TERT, etc.), could have had an impact on the results. The gene discussed is BRAF; the disease is diabetes mellitus.